logo

For the Inventor, By the Inventor

Foster City, CA, United States of America

Gilead Pharmasset LLC

Calculating rank
USPTO Granted Patents = 81

% Expired Patents = 2.5



Trademarks = 1

Forward Citations = 2,005

Loading Chart...
Loading Chart...

123 inventors (with patents filed for the assignee):

goldMedal Michael Joseph Sofia (31 out of 34 patents)

silverMedal Jinfa Du (23 out of 34 patents)

bronzeMedal Peiyuan Wang (21 out of 49 patents)

4.  John O Link (19 out of 99 patents)

5.  Ganapati Reddy Pamulapati (18 out of 19 patents)

6.  Jeromy J Cottell (17 out of 61 patents)

7.  Darryl Kato (15 out of 47 patents)

8.  Elizabeth M Bacon (15 out of 48 patents)

9.  James G Taylor (15 out of 96 patents)

10.  Bruce Ross (15 out of 18 patents)

11.  Dhanapalan Nagarathnam (15 out of 61 patents)

12.  Suguna Rachakonda (14 out of 16 patents)

13.  Teresa Alejandra Trejo Martin (13 out of 31 patents)

14.  Evan S Krygowski (13 out of 17 patents)

15.  Byoung-Kwon Chun (13 out of 28 patents)


Core Competencies:
Antiviral Compounds
HCV Treatment
Nucleoside Phosphoramidates
Combination Formulations
Nucleoside Analogues
Modified Nucleosides
Solid Forms
Synthesis Methods
Fluorinated Nucleosides
Phosphoramidate Prodrugs
Ribofuranosyl Pyrimidines
Purine Nucleosides

81 patents:

1. 11203599 - Solid forms of an antiviral compound (2021-12-21),
2. 11192875 - Processes for preparing antiviral compounds (2021-12-07),
3. 11116783 - Combination formulation of two antiviral compounds (2021-09-14),
4. 10912814 - Combination formulation of three antiviral compounds (2021-02-09),
5. 10807990 - Antiviral compounds (2020-10-20),
6. 10800789 - Antiviral compounds (2020-10-13),
7. 10604530 - Solid forms of an antiviral compound (2020-03-31),
8. 10603318 - Inhibitors of hepatitis C virus (2020-03-31),
9. 10584109 - Processes for preparing antiviral compounds (2020-03-10),
10. 10577359 - Preparation of 2'-fluoro-2′-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives (2020-03-03),
11. 10456414 - Methods for treating HCV (2019-10-29),
12. 10344019 - Antiviral compounds (2019-07-09),
13. 10335409 - Inhibitors of hepatitis C virus (2019-07-02),
14. 10287311 - Modified fluorinated nucleoside analogues (2019-05-14),
15. 10183037 - Nucleoside phosphoramidate prodrugs (2019-01-22),
Company Overview
Gilead Pharmasset LLC, based in Foster City, California, specializes in the development of antiviral compounds with a focus on innovative treatments for viral infections, particularly hepatitis C. The company is recognized for its expertise in nucleoside phosphoramidates and modified nucleosides, which are integral to its research on combination formulations and solid forms. Gilead's commitment to advancing antiviral therapies positions it as a leader in the pharmaceutical industry, driving significant advancements in patient care and treatment outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

Gilead Pharmasset LLC USPTO Patent Assignee Logo
81 Patents

#7 in Foster City, CA

#1,065 in California

#4,585 in US

#9,370 in the World

Foster City, CA (US)
Foster City, CA, United States of America

Gilead Pharmasset LLC

Forward Citations = 2,005

123 inventors:

goldMedal Michael Joseph Sofia (31 out of 34 patents)

silverMedal Jinfa Du (23 out of 34 patents)

bronzeMedal Peiyuan Wang (21 out of 49 patents)

4.  John O Link (19 out of 99 patents)

5.  Ganapati Reddy Pamulapati (18 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gilead Pharmasset LLC. Retrieved from https://idiyas.com/company/gilead-pharmasset

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…